Public-registry site landscape for NCT07678775, a Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I) study sponsored by ML Bio Solutions, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07678775 (registry record) |
| Sponsor | ML Bio Solutions, Inc. |
| Condition(s) | Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I) |
| Phase | PHASE3 |
| Listed sites | 20 |
| Site countries | United States, Australia, Denmark, Germany, Italy, Netherlands, Norway, United Kingdom |
Eichor generates a preliminary site-risk snapshot for NCT07678775 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →